Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Lincoln Pharma
Lincoln Pharma
BSE: 531633NSE: LINCOLNISIN: INE405C01035

21st-Oct-2019 14:12Source: BSE

Lincoln Pharmaceuticals - Certificate Under Regulation 40 (9) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended On September 30, 2019.

With reference to the above cited subject, please find enclose herewith Half Yearly Compliance Certificate for the Period Ended on September 30, 2019 as required to be sent under Regulation 40 (9) of SEBI (Listing and Obligations Requirements) Regulations, 2015.

More Announcements on:

1 2 3 4 5 Next >>
Sections
Follow us on
Available On